Journey Medical targets expanded Emrosi coverage and EBITDA growth through 2026 amid robust prescription demand
Journey Medical Corporation Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.09
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS